Canada’s next defence frontier: Health emergency readiness as a sovereignty imperative

Editorial by Grace Lee Reynolds (MaRS), Dr. Maura Campbell (OBIO®) and Prakash Gowd (TIAP) for CSPC's 2026 Special Editorial Series.

Life Sciences Central partners, MaRS, OBIO® and TIAP, came together to share their thoughts on the critical role Canada's domestic life sciences sector plays in the defence arena and how commercialization of homegrown health technologies and collaboration throughout the ecosystem are pivotal to our collective success.

As Dr. Maura Campbell, President and CEO of OBIO®, noted: “This is about unlocking Canada’s full economic and innovation potential, ensuring that more companies move from promising ideas to real-world health solutions, while creating jobs, IP and security wins that happen here rather than being exported to global competitors.”

Next
Next

Diamond Therapeutics Receives Multi-Million Dollar US Government Funding for Phase 2 Clinical Trial of Anxiety Treatment